A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants

Pediatrics

Volumn 132, Issue 1, 2013, Pages

  Ohls, Robin K ^a   Christensen, Robert D ^b   Kamath Rayne, Beena D ^c,d   Rosenberg, Adam ^d   Wiedmeier, Susan E ^e   Roohi, Mahshid ^a   Lacy, Conra Backstrom ^a   Lambert, Diane K ^a   Burnett, Jill J ^b   Pruckler, Barbara ^d   RonSchrader, ^e   Lowe, Jean R ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b INTERMOUNTAIN HEALTHCARE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d Children's Hospital Colorado   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Anemia; Erythropoietin; Prematurity; Transfusions

Indexed keywords

ALPHA TOCOPHEROL; ERYTHROPOIETIN; FERRITIN; FOLIC ACID; IRON; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO;

ANEMIA; ARTICLE; BIRTH WEIGHT; BLOOD CELL COUNT; BLOOD DONOR; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; FEMALE; FERRITIN BLOOD LEVEL; GESTATIONAL AGE; HEMATOCRIT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHLEBOTOMY; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; RETROLENTAL FIBROPLASIA;

EID: 84877583867     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-0143     Document Type: Article

References (45)

1. Bishara N, Ohls RK. Current controversies in the management of the anemia of prematurity. Semin Perinatol. 2009;33(1):29-34
2. Maier RF, Obladen M, Müller-Hansen I, et al European Multicenter Erythropoietin Beta Study Group. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr. 2002;141(1):8-15
3. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer. 2001;84(suppl 1):3-10
4. Warwood TL, Ohls RK, Wiedmeier SE, et al. Single-dose darbepoetin administration to anemic preterm neonates. J Perinatol. 2005;25(11):725-730
5. Warwood TL, Ohls RK, Lambert DK, et al. Intravenous administration of darbepoetin to NICU patients. J Perinatol. 2006;26(5): 296-300
6. Bell EF, Strauss RG, Widness JA, et al. Randomized trial of liberal versus restrictive guidelines for red blood cell transfusion in preterm infants. Pediatrics. 2005;115(6):1685-1691
7. Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: A randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301-307
8. Whyte RK, Kirpalani H, Asztalos EV, et al PINTOS Study Group. Neurodevelopmental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics. 2009;123(1):207-213
9. McCoy TE, Conrad AL, Richman LC, Lindgren SD, Nopoulos PC, Bell EF. Neurocognitive profiles of preterm infants randomly assigned to lower or higher hematocrit thresholds for transfusion. Child Neuropsychol. 2011;17(4):347-367
10. Nopoulos PC, Conrad AL, Bell EF, et al. Longterm outcome of brain structure in premature infants: Effects of liberal vs restricted red blood cell transfusions. Arch Pediatr Adolesc Med. 2011;165(5):443-450
11. Christensen RD. Association between red blood cell transfusions and necrotizing enterocolitis. J Pediatr. 2011;158(3):349-350
12. Baer VL, Lambert DK, Henry E, Snow GL, Christensen RD. Red blood cell transfusion of preterm neonates with a Grade 1 intraventricular hemorrhage is associated with extension to a Grade 3 or 4 hemorrhage. Transfusion. 2011;51(9):1933-1939
13. Christensen RD, Lambert DK, Baer VL, et al. Postponing or eliminating red blood cell transfusions of very low birth weight neonates by obtaining all baseline laboratory blood tests from otherwise discarded fetal blood in the placenta. Transfusion. 2011;51 (2):253-258
14. Roohi M, Peceny MC, Ohls RKA. Randomized, masked, dose response study of darbepoetin administered to preterm infants. Pediatr Res. 2007;61:14
15. Belayev L, Khoutorova L, Zhao W, et al. Neuroprotective effect of darbepoetin alfa, a novel recombinant erythropoietic protein, in focal cerebral ischemia in rats. Stroke. 2005;36(5):1071-1076
16. Ohls RK, Ehrenkranz RA, Wright LL, et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: A multicenter, randomized, controlled trial. Pediatrics. 2001;108(4):934-942
17. Ehrenkranz RA, Walsh MC, Vohr BR, et al National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005;116(6):1353-1360
18. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984;102(8): 1130-1134
19. Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529-534
20. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1-7
21. Sanchez R, Toy P. Transfusion related acute lung injury: A pediatric perspective. Pediatr Blood Cancer. 2005;45(3):248-255
22. Mohamed A, Shah PS. Transfusion associated necrotizing enterocolitis: A metaanalysis of observational data. Pediatrics. 2012;129(3):529-540
23. Haiden N, Schwindt J, Cardona F, et al. Effects of a combined therapy of erythropoietin, iron, folate, and vitamin B12 on the transfusion requirements of extremely low birth weight infants. Pediatrics. 2006;118 (5):2004-2013
24. Carroll PD, Widness JA. Nonpharmacological, blood conservation techniques for preventing neonatal anemia-effective and promising strategies for reducing transfusion. Semin Perinatol. 2012;36(4): 232-243
25. Widness JA, Madan A, Grindeanu LA, Zimmerman MB, Wong DK, Stevenson DK. Reduction in red blood cell transfusions among preterm infants: Results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics. 2005;115(5): 1299-1306
26. Baer VL, Henry E, Lambert DK, et al. Implementing a program to improve compliance with neonatal intensive care unit transfusion guidelines was accompanied by a reduction in transfusion rate: A prepost analysis within a multihospital health care system. Transfusion. 2011;51(2):264-269
27. Ohlsson A, Aher SM. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2006;(3): CD004863
28. Aher S, Ohlsson A. Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2006;(3): CD004868
29. Bearer CF, Linsalata N, Yomtovian R, Walsh M, Singer L. Blood transfusions: A hidden source of lead exposure. Lancet. 2003;362 (9380):332
30. Barger TE, Wrona D, Goletz TJ, Mytych DT. A detailed examination of the antibody prevalence and characteristics of anti-ESA antibodies. Nephrol Dial Transplant. 2012; 27(10):3892-3899
31. Ohls RK, Roohi M, Peceny HM, Schrader R, Bierer R. A randomized, masked study of weekly erythropoietin dosing in preterm infants. J Pediatr. 2012;160(5):790-795.e1
32. Ohls RK, Harcum J, Schibler KR, Christensen RD. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: A randomized, double-blind, placebo-controlled study. J Pediatr. 1997;131(5):661-665
33. Romagnoli C, Zecca E, Gallini F, Girlando P, Zuppa AA. Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity? Eur J Pediatr. 2000;159(8): 627-628
34. McPherson RJ, Juul SE. Recent trends in erythropoietin-mediated neuroprotection. Int J Dev Neurosci. 2008;26(1):103-111
35. Digicaylioglu M, Lipton SA. Erythropoietinmediated neuroprotection involves crosstalk between Jak2 and NF-kappaB signalling cascades. Nature. 2001;412(6847):641-647
36. Kumral A, Baskin H, Gokmen N, et al. Selective inhibition of nitric oxide in hypoxicischemic brain model in newborn rats: Is it an explanation for the protective role of erythropoietin? Biol Neonate. 2004;85(1): 51-54
37. Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem Pharmacol. 2000;59(4):419-425
38. Akisu M, Tuzun S, Arslanoglu S, Yalaz M, Kultursay N. Effect of recombinant human erythropoietin administration on lipid peroxidation and antioxidant enzyme(s) activities in preterm infants. Acta Med Okayama. 2001;55(6):357-362
39. Genc S, Akhisaroglu M, Kuralay F, Genc K. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine- induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro. Neurosci Lett. 2002;321(1-2):73-76
40. Vairano M, Dello Russo C, Pozzoli G, et al. Erythropoietin exerts anti-apoptotic effects on rat microglial cells in vitro. Eur J Neurosci. 2002;16(4):584-592
41. Sugawa M, Sakurai Y, Ishikawa-Ieda Y, Suzuki H, Asou H. Effects of erythropoietin on glial cell development; oligodendrocyte maturation and astrocyte proliferation. Neurosci Res. 2002;44(4):391-403
42. Beirer R, Peceny MC, Hartenberger CH, Ohls RK. Erythropoietin concentrations and neurodevelopmental outcome in preterm infants. Pediatrics. 2006;118(3). Available at: Www.pediatrics.org/cgi/content/full/118/3/e635
43. Brown MS, Eichorst D, Lala-Black B, Gonzalez R. Higher cumulative doses of erythropoietin and developmental outcomes in preterm infants. Pediatrics. 2009; 124(4). Available at: Www.pediatrics.org/cgi/content/full/124/4/e681
44. Neubauer AP, Voss W, Wachtendorf M, Jungmann T. Erythropoietin improves neurodevelopmental outcome of extremely preterm infants. Ann Neurol. 2010;67(5):657-666
45. McAdams RM, McPherson RJ, Mayock DE, Juul SE. Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol. 2013;33(3):226-230